baber/WOPTO huggingface dataset:
Patent FI-961414-A0 (FI)
Inventor: TIEDEMANN JR EDWARD G
IPC: H04B7/00
Filed: 1996-03-28
Abstract: A method and apparatus for controlling transmission power in a variable rate communication system is disclosed. The method disclosed provides for a closed loop power control method. A first remote station controls the transmission power of a second remote station by transmitting a rate dependent power control signal to the second remote communication station. Since only the second communication knows its transmission rate a priori, it must determine its course of action in accordance with both the received power control signal and the knowledge of its transmission rate.
Patent AP-9400659-A0 (AP)
Title: Container for water transport
Inventor: KLOPPERS FREDERICK CHRISTIAAN
Filed: 1994-07-27
Abstract: A device to transport liduid consting of a cylinder or any other shaped container
Patent IL-61600-A0 (IL)
Title: Diphenylmethane derivative,process for its preparation and pharmalceutical compositions containing it
IPC: C07C303/06
Filed: 1980-12-01
Abstract: For the Contracting States : DE, FR, IT, NL, BE, CH, GB, SE, LI, LU) 1. 2,2'-Dihydroxy-5,5'-methylenedi-(p-toluene-sulphonic acid) and its salts. For the Contracting State : AT 1. Process for the preparation of 2,2'-dihydroxy-5,5'- methylenedi-(p-toluenesulphonic acid) and its salts, characterized in that a) m-cresol-6-sulphonic acid and/or its salts are reacted in an acid medium with formaldehyde and/or formaldehyde donors and, if desired, a resulting salt is converted into the free acid or into another salt, b) m-cresol-6-sulphonic acid and/or its salts are converted, in a basic medium, by means of form-aldehyde and/or formaldehyde donors into 4-hydroxymethyl-m- cresol-6-sulphonic acid and the latter is subjected in an acid medium to a condensation reaction with m-cresol-6-sulphonic acid and/or its salts and, if desired, a resulting salt is converted into the free acid or into a another salt, or c) m-cresol which is substituent in the 6-position by a detachable substituent is reacted, in an acid medium, with formaldehyde and/or formaldehyde donors to give a 5,5'-disubstituted 4,4'-dihydroxy-2,2'-dimethyl diphenylmethane, the substituents in the 5-position and 5'-position are split off and the product is sulphonated in an acid medium with sulphuric acid and/or an agent which splits off sulphonic acid groups and, if appropriate, a resulting salt is converted into the free acid or into another salt.
Patent IL-67835-A0 (IL)
Title: Imidazolidine derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07D263/58
Filed: 1983-02-04
Abstract: Imidazolidine derivatives of the formula:   <IMAGE>   wherein R1 represents the hydroxy radical and R2 represents a grouping -NHSO2CH3, -NHCOR' or -NHCONR'R'', R' and R'' independently of one another representing a hydrogen atom or an alkyl radical having from 1 to 4 carbon atoms, or alternatively R2 represents the hydroxy radical and R1 represents a grouping -NHSO2CH3, -NHCOR' or ?NHCONR'R'', R' and R'' independently of one another representing a hydrogen atom or an alkyl radical having from 1 to 4 carbon atoms, and pharmacologically-acceptable acid addition salts thereof, are new therapeutically useful compounds. They are more particularly useful in the treatment of gastric hypersecretion or hyperacidity or glaucoma.
Patent IL-79008-A0 (IL)
Title: Method and apparatus for positioning articles
IPC: B65G47/14
Filed: 1986-06-03
Abstract: A method and apparatus for positioning an article (4) having opposed ends at least one of which is flat and an irregular surfaced body portion between the ends so that the article (4) can stably rest on the flat end including feeding one or more of such articles (4) to a substantially horizontal support surface (3) in random orientation and imparting a simultaneous back-and-forth and side-to-side motion on the surface (3) with the resulting forces on each article (4) created by such motion causing each article to seek a stable position bringing each article to rest on the flat end of the article (4).
Patent IL-83803-A0 (IL)
Title: Ceramic composite structures having intrinsically fitted encasement members thereon and methods of making the same
IPC: C22C29/00
Filed: 1987-09-06
Abstract: A method is provided of producing a self-supporting ceramic composite structure having one or more encasement members (14), such as an encasing stell sleeve, joined to it by growth of the ceramic material to engagement surface(s) of the encasement member(s) (14). A parent metal is contacted with a body of filler (38) which is encased by the encasement mmber(s) (14). The resulting assembly is heated to melt and oxidize the parent metal, e.g., aluminum, to form a polycrystalline material comprising an oxidation reaction product which grows through the body of filler (38) and stops at the engagement surface(s) of the encasement member(s) (14) which thereby determines the surface geometry of the grown ceramic matrix. Upon cooling, the encasement member(s) (14) is shrinkfitted about the ceramic composite body. The invention also provides the resultant articles, for example, a ceramic composite body having a stainless steel member affixed thereto.
Patent IL-84189-A0 (IL)
Title: Pharmaceutical compositions containing tumor necrosis factors and anti-inflammatory agents
IPC: A61P29/00
Filed: 1987-10-16
Abstract: Combinations and methods for the treatment of malignant and non-malignant diseases. More particularly, this invention relates to combinations of natural or recombinant tumor necrosis factors (''TNF'') and non-steroidal anti-inflammatory agents, such as indomethacin and ibuprofen, useful for the growth inhibition or killing of transformed cells. According to this invention, the non-steroidal anti-inflammatory agents are used to reduce or eliminate the toxic side effects of high doses of TNFs employed in the treatment of malignant and non-malignant neoplastic diseases. Advantageously, the combinations and methods of this invention allow the administration of higher doses of TNF than those tolerated in conventional treatment regimens based upon TNF alone.
Patent IL-84229-A0 (IL)
Title: Human apolipoprotein ai and variant form thereof expressed in escherichia coli
IPC: C12N1/20
Filed: 1987-10-20
Abstract: An expression vector capable of expressing, in a transformed host, a protein which is capable of being detected by ELISA with anti-human apoAI antiserum and which has the formula (1) Met-X-Y      (1) wherein X is a b                                               ond, a carrier peptide sequence which comprises a sequence derived from the N-terminal amino acid residues of beta-galactosidase or a sequence comprising one or more IgG-binding domains of Protein A, or the pro sequence of human apoAI; and Y represents the sequence of human apoAI or a genetic variant thereof. Hosts transformed with such vectors produce the protein, which is useful in the treatment of atherosclerosis and cardiovascular diseases.
Patent IL-89789-A0 (IL)
Title: Communication system having packet structure field
IPC: H04L12/28
Filed: 1989-03-29
Abstract: A communication system develops an information packet having a packet structure field and at least one message. The message has an address and information associated with the address. A central station accumulates and incorporates the at least one message into the information packet. The central station determines the occurrence of the at least one address and generates identifying data indicating where the address occurs within the information packet. The identifying data is incorporated into the packet structure field and the information packet is transmitted. The information packet is received by at least one selective call receiver capable of operating in a high power mode in order to receive the information packet and a low power mode when receiving is not being performed. The selective call receiver extracts the packet structure field and interprets the identifying data. The identifying data is used to operate the selective call receiver in the high power mode only during the occurrence of the at least one address. The selective call receiver operates in the low power mode for the remainder of the information packet unless the information associated with the address is intended to be received by the selective call receiver.
Patent AU-PR436901-A0 (AU)
Title: Apparatus for injecting gas into a vessel
IPC: C21C5/46
Filed: 2001-04-11
Abstract: An injection lance (26) for injecting hot gas into a vessel includes an elongate gas flow duct (31) which receives hot gas from a gas inlet structure (32) and an elongate central tubular structure (33) which extends within gas flow duct (31) from its rear end to its forward end. Adjacent the forward end of duct (31), central structure (33) carries a series of flow directing vanes (34) for imparting swirl to the hot gas flow exiting the duct. The wall of duct (31) downstream from gas inlet (32) is internally water cooled by flow of water through annular passages (43,44). The cooling water also flows through the interior of a duct tip (36) at the forward end of duct (31). The front end of central structure (33) which carries the swirl vanes (34) is internally water cooled by cooling water supplied forwardly through a central water flow passage (52) from a water inlet (53) at the rear of the lance through to a nose (35) of the central structure. The cooling water returns back through the central structure via an annular water return passage (54) to a water outlet (55) at the rear end of the lance.
Patent FI-20000928-A0 (FI)
Inventor: MALMSTROEM OLOFY
IPC: D21H21/16
Filed: 2000-04-18
Abstract: A modified filler used in the making of paper or the like, preparation of the filler and its use. The modified filler comprises a filler known as such, e.g. Calcium carbonate, kaolin, talc, titanium dioxide, sodium silicate and aluminum trihydrate or their mixture, and a hydrophobic polymer made of polymerisable monomers, which is added to the filler as a polymer dispersion or a polymer solution.
Patent FI-20012369-A0 (FI)
IPC: G01R31/36
Filed: 2001-12-03
Abstract: A method and apparatus for simulating the operation of a rechargeable battery. A value is obtained for at least one parameter that describes an internal state of the battery. The obtained value is used for calculating a prediction value for a characteristic of the battery that is observable outside the battery. These steps are repeated a multitude of times in order to simulate the operation of the battery over a certain period of time. A difference is detected between a calculated prediction value and a known value of a corresponding characteristic in a corresponding situation. The obtained value of the at least one parameter is corrected before a further prediction value is calculated by an amount that is proportional to the detected difference.
Patent FI-20115827-A0 (FI)
Inventor: TALONEN TAPANI
IPC: B66B/
Filed: 2011-08-26
Abstract: The invention relates to an elevator (1) and also to a drive unit (5) for driving an elevator. The elevator according to the invention comprises one or more hoisting members (2, 30A, 30B) that are continuous in the vertical direction, a load-receiving part (3) suspended on the hoisting member (2), and also a driving member (4) engaging with the hoisting member (2, 30A, 30B) for moving the load-receiving part (3). The aforementioned driving member (4) engaging with the hoisting member is configured to be driven with a detachable drive unit (5).
Patent IL-101751-A0 (IL)
Title: Stable pur a vectors and uses thereof
IPC: C12N15/74
Filed: 1992-04-30
Abstract: This invention pertains to a complementation system for the selection and maintenance of expressed genes in bacterial hosts. The invention provides stable vectors which can be selected and maintained by complementation of chromosomal deletion mutations of purA (adenylosuccinate synthetase), obviating the use of antibiotic resistance genes. This system is useful in production organisms during fermentation and in live vaccine bacteria, such as attenuated Salmonella typhi. This system allows for selection of chromosomal integrants and for selection and stable plasmid maintenance in the vaccinated host without application of external selection pressure.
Patent IL-105657-A0 (IL)
Title: Process for the preparation of 5-chloroxindole
IPC: C07C205/56
Filed: 1993-05-10
Abstract: There is described a novel process for the preparation of 5-chlorooxindole starting from p-chloronitrobenzene. In this process, in the first step chloronitrobenzene of the formula 
 <IMAGE> 
 is converted with an alkyl chloroacetate of the general formula 
 <IMAGE> 
 in the presence of a base to an alkyl chloronitrobenzeneacetate of the general formula 
 <IMAGE> 
 this is hydrogenated catalytically in the second step with hydrogen to give the corresponding amine of the general formula 
 <IMAGE> 
 and this is then cyclised in the third step in the presence of an acid to give the final product according to the formula 
 <IMAGE>
Patent IL-106089-A0 (IL)
Title: 9-amino-pyridazino(4',5':3,4)pyrrolo(2,1-a)isoquinolines,their production and pharmaceutical compositions containing them
IPC: C07D471/14
Filed: 1993-06-21
Abstract: The invention relates to the use of 9-amino-pyridazino-[4', 5':3,4]pyrrolo[2,1-a]isoquinolines of the formula    <IMAGE>  (I)  and the physiologically acceptable salts thereof with acids, bases and complexing agents for preparing agents for treating chronic inflammatory processes, ulcerative colitis and Crohn's disease, and for producing agents having an antiproliferative activity. The definitions of substituents R1 to R9 are given in the specification. The invention also relates to new compounds of general formula I which are also defined in the specification and their use as cerebroprotective agents.
Patent IL-108528-A0 (IL)
Title: Pulmonary administration of epo
IPC: A61K9/72
Filed: 1994-02-02
Abstract: Described is the use of erythropoietin (EPO) for the preparation of a pharmaceutical composition for pulmonary administration or inhalation. Aerosol administration of EPO in accordance with this invention results in significant elevation of red blood cell levels. EPO can be administered in this manner to medically treat or prevent anemia, as well as to treat or prevent other maladies related to erythropoiesis.
Patent IL-114212-A0 (IL)
Title: Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
IPC: A61K9/107
Filed: 1995-06-19
Abstract: This invention is directed to a composition of a taxine in a stable oil-in-water emulsion for intravenous administration. The invention also relates to a method for incorporating a taxine into an oil and making a stable oil-in-water emulsion. The composition includes a taxine, an oil, water and a surfactant. In a preferred embodiment, the taxine is taxol, the oil is safflower oil and the surfactant is lecithin, The taxine is incorporated into the oil by dissolving the taxine in a solution of an oil and a taxine co-solvent, such as isopropanol, for example. The co-solvent then is removed to form a solution of the taxine in oil. This solution may be dispersed in water with a surfactant to form a stable oil-in-water emulsion for intravenous administration.
Patent IL-116950-A0 (IL)
Title: Tension arm developer apparatus
IPC: G03F7/26
Filed: 1996-01-29
Abstract: A pressure developing apparatus is described for use in developing images in the image area of a photosensitive imaging sheet containing microcapsules, wherein the apparatus comprises: an arm which oscillates in arcuate paths across the surface of the imaging sheet; means for oscillating the arm across the surface of the imaging sheet; means for establishing longitudinal movement between the arm and the imaging sheet; and a developer head positioned along the shaft of the arm, the developer head further containing at least one point contact element which is resiliently biased into contact with a surface of the imaging sheet such that the point contact element traverses the surface of the imaging sheet in sequential increments to provide a plurality of paths and applies uniform pressure sufficient to rupture the microcapsules in substantially the entire image area.
Patent IL-127201-A0 (IL)
Title: Process for preparing nicotinic acid
IPC: C07D213/803
Filed: 1998-11-23
Abstract: A method for the production of nicotinic acid (I) involves spray-drying an aqueous solution of ammonium nicotinate to form (I) followed by thermal treatment in a fluidized bed at 100-200 (preferably 130-170) degrees C or under reduced pressure (preferably at below 50 mbar) at 70-150 (preferably 80-120) degrees C.
Patent IL-134532-A0 (IL)
Title: Photovoltaic module and method for producing same
IPC: H01L31/048
Filed: 1999-06-30
Abstract: A photovoltaic module (1) in the form of a laminate with a solar cell system (2) as the core between encapsulating materials (3, 3'), in which at least one of these materials (3') comprises a sealing layer (4') and a barrier layer (6) consisting of a plastic film or compound foil with an inorganic oxide layer (7) deposited from the vapor phase. An Independent claim is also included for a process for the production of a module (1) by (a) vapor-phase deposition of an oxide layer (7) on a plastic film or compound foil (6), (b) encapsulation of a solar cell system (2) between sealing layers (4, 4'), (c) transferring the module stack to the loading station of a system in which it is kept at a temperature below the softening point of layers (4, 4'), (d) transferring the stack to a vacuum laminator in which it is heated under vacuum to the softening point of (4, 4') and (e) letting in air without cooling, transferring the composite body to a hardening oven and hardening layers (4, 4') to form a laminated module (2) which is then cooled and taken out for further processing.
Patent IL-141126-A0 (IL)
Title: Herpes virus vectors for dendritic cells
IPC: C12N15/869
Filed: 1999-08-02
Abstract: An attenuated herpes virus capable of efficiently infecting a dendritic cell without preventing antigen processing occurring within the infected cell. The attenuated herpes virus and dendritic cells infected with the virus are useful immunotherapeutic methods of treating disease.
Patent IL-147031-A0 (IL)
Title: Computational design methods for making molecular mimetics
IPC: C07K1/107
Filed: 2000-08-02
Abstract: Methods are proposed for the design and synthesis of a molecule which mimics the activity of a parent molecule. In particular the methods relate to computationally identifying chemical groups of a parent molecule for inclusion in a mimetic, designing a mimetic taking into account the folding structure of the parent, designing a mimetic using a relative geometrical relationship of chemical groups in the parent molecule, designing a mimetic using a molecular dynamics simulation of the mimetic, and screening potential mimetics using molecular dynamics simulation.
Patent IL-147663-A0 (IL)
Title: Electrosurgical probe for tumor treatment by radiofrequency
IPC: A61B18/14
Filed: 2000-07-19
Abstract: An electrosurgical probe including a metal cannula, partially provided with an electroinsulating coating, and filiform electrodes housed in the cannula in a stretched position. The filiform electrodes are provided with an elastic memory of an arched shape and as a result, come out from the cannula to occupy a limited, nearly spherical volume. The electrodes are fixed to the distal end of a control rod slidably arranged inside the cannula so that the electrodes in a stretched position are arranged side by side parallel with the control rod. The cannula includes a series of holes each positioned immediately under the free ends of the filiform electrodes and having a sufficient diameter for the passage of a respective one of the electrodes. The electrodes are removed from the cannula by pulling the control rod and retracted into the cannula by pushing the control rod.
Patent IL-148782-A0 (IL)
Title: Drugs for the treatment of malignant tumours
IPC: C07D/
Filed: 2000-10-24
Abstract: The invention relates to the use of compounds of general formula (I) or any tautomer, optical isomer or racemate thereof for the manufacturing of a medicament for the treatment of cancer. The invention also comprises novel compounds, pharmaceutical compositions, and processes for the preparation of the compounds of formula (I).
Patent IL-149835-A0 (IL)
Title: System-side connecting module and distributor for telecommunications technology
IPC: H04Q1/06
Filed: 2000-11-24
Abstract: A telecommunications backbone junction module (10) is configured in the form of a cable connector for mounting in a telecommunications rack-mounting system and comprises through-contact elements for joining, particularly prefabricated, conductors of a backbone cable (12) on the one hand, and, on the other, IDC contacts in a front portion in the mounting position for joining the patching cables (14).
Patent IL-155150-A0 (IL)
Title: Process for production of an absorbing sanitary article comprising lactic acid producing bacteria
IPC: A61L15/36
Filed: 2001-09-19
Abstract: The present invention relates to a process for the production of an absorbing sanitary article comprising lactic acid producing bacteria. The process comprises dispersion of lactic acid producing bacteria in a carrier, and application of the resulting dispersion of bacteria by continuous or discontinuous gentle feeding on and/or in at least one component that are to form part of the final article. Furthermore, the present invention relates to an absorbing sanitary article comprising lactic acid producing bacteria dispersed in an essentially hydrophobic carrier. The dispersion of bacteria forms at least one continuous or discontinuous string on and/or in the final sanitary article.
Patent IL-156396-A0 (IL)
Title: Chassis for front and back inserted modules
IPC: H05K7/14
Filed: 2001-12-18
Abstract: Methods, systems and devices are described relating to a chassis for front and back inserted modules. An apparatus includes a chassis including a first module bay and a second module bay, the first module bay and the second module bay together composing both a forward section and rearward section.
Patent IL-159637-A0 (IL)
Title: Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
IPC: A61K48/00
Filed: 2002-07-10
Abstract: Described are compositions and methods relating to gene therapy, particularly as applied to hematopoietic progenitor (HP) cells, to transduced cells and methods of obtaining them, and to methods of using them to provide prolonged engraftment of modified hematopoietic cells in human subjects. The invention particularly relates to ex vivo gene therapy of HP cells for treatment or prevention of HIV infection.
Patent IL-175030-A0 (IL)
Title: Immunotherapic agent which is used for the combined treatment of tuberculosis together with other pharmaceuticals
IPC: A61K39/04
Filed: 2006-04-20
Abstract: This invention relates to an immunotherapeutic agent, which is based on cell wall fragments from a virulent strain of  Mycobacterium tuberculosis,  to a method of obtaining said agent, to pharmaceutical compositions containing same and to the use thereof for the preparation of a medicament for the combined treatment of tuberculosis in association with other drugs.
Patent IL-186638-A0 (IL)
Title: Dosing elements for a drip irrigation tube and method and device for producing these dosing elements
Filed: 2007-10-14
Abstract: One side of a band (3) is connectible to the walling of the tube body (2) forming a drip irrigation tube (1). Each of a structured areas (6) comprises an inlet region, a dosing region, and an outlet region. The band comprises of a longitudinally stable, flexible support band (4) provided on one side with a layer in which the structured areas are provided. Independent claims are also included for the following: (1) a method of producing dosing element for drip irrigation tube; (2) and a device for producing dosing element for drip irrigation tube.